Combining molecular biology with cancer imaging and treatment strategies
INTEGRATING MOLECULAR BIOLOGY WITH CANCER MOLECULAR IMAGING AND THERANOSTICS
This study is exploring new ways to help people with kidney cancer by using advanced techniques to turn off certain genes that help the cancer grow, which could lead to better imaging and more personalized treatment options for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10912713 on NIH RePORTER |
What this research studies
This research focuses on integrating advanced molecular biology techniques with cancer molecular imaging and theranostics, particularly in the context of kidney cancer. The project aims to develop methods to silence specific genes involved in cancer progression, using innovative approaches like siRNA and shRNA. By studying the hypoxia inducible factor (HIF-1) and its role in renal carcinoma, the research seeks to enhance the understanding of cancer biology and improve imaging techniques that can guide treatment decisions. Patients may benefit from advancements in targeted therapies and personalized treatment plans based on molecular insights.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with kidney cancer who may benefit from targeted molecular therapies.
Not a fit: Patients with non-cancerous conditions or those not diagnosed with kidney cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for kidney cancer patients.
How similar studies have performed: Previous research has shown promise in using molecular biology techniques for cancer treatment, indicating potential success for this integrated approach.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Krishnamachary, Balaji — Johns Hopkins University
- Study coordinator: Krishnamachary, Balaji
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.